Novartis (NVS) market cap

Market cap today
$300.54B

Novartis (NVS) has a market cap of $300.54B. At the end of fiscal 2025 (December 31, 2025) its market cap was $269.54B. That is 36.1% higher than the $198.03B of fiscal 2024. Today's figure is 11.5% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:04 UTC, from Yahoo Finance.

Key facts

Market cap today
$300.54B
Market cap, fiscal 2025
$269.54B
Change on fiscal 2024
+36.1%
Highest on record
$269.54Bfiscal 2025
Lowest on record
$198.03Bfiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis market cap, in more detail

Across the 4 fiscal year-ends on record (2022–2025), the highest was $269.54B in fiscal 2025 and the lowest $198.03B in fiscal 2024.

History · 4 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Novartis market cap, year by year

Novartis (NVS) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$300.54B—$159.13—
2025$269.54B 36.1% up$137.871.96B
2024$198.03B 6.3% down$97.312.04B
2023$211.23B 6.0% up$100.972.09B
2022$199.31B—$90.722.20B

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Novartis and comparable companies
CompanyMarket cap
AbbVie ABBV$517.59B
Merck & Co MRK$353.44B
UnitedHealth Group UNH$349.16B
Novartis NVS$300.54B
AstraZeneca AZN$282.69B
Thermo Fisher Scientific TMO$254.47B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis market cap: questions and answers

What is Novartis's market cap?

Novartis (NVS) has a market cap of $300.54B. At the end of fiscal 2025 (December 31, 2025) its market cap was $269.54B. That is 36.1% higher than the $198.03B of fiscal 2024.

What are the highest and lowest market cap figures on record for Novartis?

Across the 4 fiscal year-ends on record (2022–2025), the highest was $269.54B in fiscal 2025 and the lowest $198.03B in fiscal 2024.

How is Novartis's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/market-cap

Underlying data: Yahoo Finance.